RCT: Among patients younger than 21 years of age with provoked thromboembolism, anticoagulation for 6 weeks was non-inferior vs. 12 weeks on the risk of recurrence and bleeding events.
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial – JAMA (free for a limited period) Editorial: Duration of Anticoagulant Treatment for Acute Provoked Venous Thromboembolism in Pediatric Patients – JAMA (free […]
The post RCT: Among patients younger than 21 years of age with provoked thromboembolism, anticoagulation for 6 weeks was non-inferior vs. 12 weeks on the risk of recurrence and bleeding events. appeared first on Links Medicus.
Discriminative accuracy of chronic obstructive pulmonary disease screening instruments in 3 low- and middle-income country settings.
Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings – JAMA (free for a limited period) Editorial: Screening for Chronic Obstructive Pulmonary Disease: Unmet Needs and Future Considerations News release: Simple screening for common lung disease could relieve millions globally – University College London Commentary from the […]
The post Discriminative accuracy of chronic obstructive pulmonary disease screening instruments in 3 low- and middle-income country settings. appeared first on Links Medicus.
German Guideline: Oxygen therapy in the acute care of adult patients.
German S3 Guideline: Oxygen Therapy in the Acute Care of Adult Patients – Respiration
The post German Guideline: Oxygen therapy in the acute care of adult patients. appeared first on Links Medicus.
Perspective | Covid-19: Is it safe to reduce the self-isolation period?
Covid-19: Is it safe to reduce the self-isolation period? – The BMJ
The post Perspective | Covid-19: Is it safe to reduce the self-isolation period? appeared first on Links Medicus.
Podcast: Long COVID Pearls.
#315 Long COVID with Dr. Monica Verduzco-Gutierrez – The Curbsiders
The post Podcast: Long COVID Pearls. appeared first on Links Medicus.
Statement on potential drug-drug interactions between Ritonavir-boosted Nirmatrelvir (Paxlovid) and concomitant medications; antiarrhythmics, oral anticoagulants, immunosuppressants, anticonvulsants, antineoplastics, and neuropsychiatric drugs are among t
The COVID-19 Treatment Guidelines Panel’s Statement on Potential Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Concomitant Medications – NIH COVID-19 Treatment Guidelines Panel Commentaries: Pfizer antiviral pills may be risky with other medications – NBC News The New COVID-19 Pill, Paxlovid, Interacts with Many Medications: Cardiac Patients Take Note – The Skeptical Cardiologist See also: […]
The post Statement on potential drug-drug interactions between Ritonavir-boosted Nirmatrelvir (Paxlovid) and concomitant medications; antiarrhythmics, oral anticoagulants, immunosuppressants, anticonvulsants, antineoplastics, and neuropsychiatric drugs are among the drugs of concern. appeared first on Links Medicus.
The COVID-19 Treatment Guidelines Panel’s Statement on Anticoagulation in Hospitalized Patients With COVID-19 – in the absence of contraindications, use therapeutic-dose anticoagulation with low molecular weight heparin for hospitalized patients not in th
The COVID-19 Treatment Guidelines Panel’s Statement on Anticoagulation in Hospitalized Patients With COVID-19 – NIH COVID-19 Treatment Guidelines
The post The COVID-19 Treatment Guidelines Panel’s Statement on Anticoagulation in Hospitalized Patients With COVID-19 – in the absence of contraindications, use therapeutic-dose anticoagulation with low molecular weight heparin for hospitalized patients not in the ICU who have a D-dimer above the upper limit of normal. appeared first on Links Medicus.
Statement on therapies for high-risk, nonhospitalized patients with mild to moderate Covid-19.
The COVID-19 Treatment Guidelines Panel’s Statement on Therapies for High-Risk, Nonhospitalized Patients With Mild to Moderate COVID-19 – NIH COVID-19 Treatment Guidelines See also: What’s New in the Guidelines – NIH COVID-19 Treatment Guidelines
The post Statement on therapies for high-risk, nonhospitalized patients with mild to moderate Covid-19. appeared first on Links Medicus.
Omicron’s feeble attack on the lungs could make it less dangerous.
Omicron’s feeble attack on the lungs could make it less dangerous – Nature
The post Omicron’s feeble attack on the lungs could make it less dangerous. appeared first on Links Medicus.
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19.
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19 – Covid Advisory for Ontario Commentary on Twitter Fantastic outpatient treatment approach from Ontario #COVID19 Clinical Practice GuidelinesRisk level:high mod lowEg:high:Sotrovimab is recommended if NA Remdesivir if NA Fluvoxamine or BudesonidePaxlovid/Molnupiravir not added coz not yet approved CA https://t.co/dDhj6vA0uv pic.twitter.com/4ucrKIcMn8 — […]
The post Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19. appeared first on Links Medicus.